Be Swasth Healthcare Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.12 Cr
as on 16-11-2024
- Company Age 39 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.95 M
as on 16-11-2024
About Be Swasth Healthcare
The Corporate was formerly known as Ujala Commercials Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.12 Cr.
The company has closed loans amounting to ₹2.95 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Be Swasth Healthcare Limited India are Amit Kumar as COMPANY SECRETARY and Sushma Jain as Cfo. Virender Jain, Nirmal Jain, Ganesh Ray, and Two other members serve as directors at the Company.
- CIN/LLPIN
L93000DL1985PLC021397
- Company No.
021397
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Jul 1985
- Date of AGM
10 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Be Swasth Healthcare?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushma Jain  | Managing Director | 26-Aug-2019 | Current |
| Amit Kumar | Company Secretary | 23-Jul-2024 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Virender Jain | Director | 05-Mar-1999 | Current |
| Nirmal Jain | Director | 10-May-2006 | Current |
| Ganesh Ray | Director | 10-Feb-2016 | Current |
| Sonali Gupta | Director | 11-Aug-2021 | Current |
Financial Performance and Corporate Structure Insights of Be Swasth Healthcare.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Be Swasth Healthcare?
Unlock access to Be Swasth Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kadimi Sweets Private LimitedActive 29 years 7 monthsVirender Jain and Nirmal Jain are mutual person
- Federation Of Sweets & Namkeen ManufacturersActive 6 years 3 months
Virender Jain is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 07 Oct 2006 | ₹2.95 M | Satisfied |
How Many Employees Work at Be Swasth Healthcare?
Unlock and access historical data on people associated with Be Swasth Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Be Swasth Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Be Swasth Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
